{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Voyager Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"VYGR"},"Address":{"label":"Address","value":"75 SIDNEY STREET, CAMBRIDGE, Massachusetts, 02139, United States"},"Phone":{"label":"Phone","value":"+1 857 259-5340"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. The company operates in a single segment of developing and commercializing gene therapies."},"CompanyUrl":{"label":"Company Url","value":"https://www.voyagertherapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alfred W. Sandrock","title":"President, Chief Executive Officer & Director"},{"name":"Robin Swartz","title":"Chief Operating Officer"},{"name":"Toby Ferguson","title":"Chief Medical Officer"},{"name":"Todd Carter","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}